Lung Cancer Study Group
N E W S - A R C H I V E
The campaign by the Lung Cancer Study Group (GECP), launched to mark World Patient Day (February 11th), proposes a paradigm shift in Oncology. More than just fighting the progression of the disease, the goal is to care for the lives…
A study by the Spanish Lung Cancer Group (GECP), published in Clinical Cancer Research, demonstrates that a blood test capable of detecting Minimal Residual Disease (MRD) after surgery significantly improves the prediction of relapse risk. The results reveal that, although…
The latest edition of THORAC magazine is now available. Packed with updated articles and analyses, this edition highlights new advances in the diagnosis and treatment of lung cancer. Explore the contents of this new edition and stay informed about the…
No passado dia 17 de janeiro, o Hotel Dona Inês, em Coimbra, acolheu a reunião de Brainstorming do Grupo de Estudos do Cancro do Pulmão (GECP). Este encontro estratégico teve como principal objetivo o planeamento das atividades do Grupo para…
Deco Proteste recently interviewed Prof. Gabriela Fernandes, member of the Board of Directors of the Lung Cancer Study Group (GECP), about lung cancer screening pilot projects. According to the Pulmonology specialist, these projects represent “an essential step in the fight…
The article “Full Lung Cancer Screening Uptake Could Save 47,000 Additional Lives, Researchers Suggest” highlights the potential of lung cancer screening to save lives. Studies show that more than 62,000 deaths could be prevented in five years in the US…
In an interview with News Farma, Dr. Ana Figueiredo, President of the Board of Directors of the Lung Cancer Study Group (GECP), highlighted the high participation in the last edition of the Autumn Meeting, which provided a comprehensive review of…
The Lung Cancer Study Group (GECP) wishes everyone a Christmas full of joy, health, and good times.The GECP Board takes this festive season to express its best wishes to the entire community involved in the study and fight against lung…
Dr. Daniela Madama, a member of the Scientific Committee of the Lung Cancer Study Group (GECP), authored an exclusive opinion piece, published in the Jornal de Notícias, dedicated to the issue of lung cancer. The pulmonologist reflects on the evolution…
Dr. Ana Rodrigues, oncologist and member of the Scientific Committee of the Lung Cancer Study Group (GECP), led the conference “New Drugs, New Toxicities,” highlighting the challenges of new therapies in the treatment of lung cancer. Regarding the main differences…
Roundtable 3: Patient Well-being focused on three fundamental themes aimed at humanizing care for lung cancer patients. Dr. Margarida Felizardo, a member of the Scientific Committee of the Lung Cancer Study Group (GECP), moderated the session and highlighted the importance…
Roundtable 2: News from Congresses – Therapeutic Innovation was moderated by several members of the Lung Cancer Study Group (GECP), including Dr. Cristina Rodrigues. The specialist in Thoracic Surgery, and member of the GECP Board, gave a positive assessment of…
